Patent · US Active

Predicting lung cancer survival using gene expression

US8202968B2 · kind B2 · utility

0Cited by
0References
1Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 19, 2007
Grant dateJun 19, 2012
Priority date
Expiry dateOct 19, 2027

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Q2600/118
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention provides a plurality of biomarkers for predicting survival of a subject with a lung cancer. More specifically, the present invention relates to methods of predicting survival of a subject with a lung cancer, a kit for predicting survival of a subject with a lung cancer, and an array for predicting survival of a subject with lung cancer.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.